A member asked:

Best first-line treatment for mantle cell lymphoma now: high doses of ara-c+rituximab and autologous sc transplant, or rituximab+bendamustine?

A doctor has provided 1 answer
Dr. Michael Dugan answered

Specializes in Hematology

There is no: Definitive answer to your question. Studies have compared the strategies you mention. The high dose ara-c arm was closed because it was difficult to mobilize stem cells for transplant after these regimens. Bendamustine-r is a good program, and many centers would consolidate a good response with an autograft.

Answered 11/24/2013

4.7k views

Thank

Related Questions